*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ Donald/NNP E./NNP Panoz/NNP ]
thinks/VBZ 
[ drug/NN research/NN ]
and/CC 
[ development/NN ]
is/VBZ 
[ risky/JJ business/NN ]
./. 

[ He/PRP ]
ought/MD to/TO know/VB ./. 

======================================

[ Mr./NNP Panoz/NNP ]
has/VBZ spent/VBN 
[ 20/CD years/NNS ]
building/VBG 
[ Elan/NNP Corp./NNP PLC/NNP ]
into/IN 
[ a/DT top/JJ pharmaceutical/JJ research/NN company/NN ]
./. 

[ Its/PRP$ specialty/NN ]
is/VBZ adapting/VBG 
[ medications/NNS ]
to/TO make/VB 
[ them/PRP ]
more/RBR effective/JJ when/WRB administered/VBN to/TO 
[ patients/NNS ]
./. 

======================================

While/IN 
[ Elan/NNP ]
has/VBZ been/VBN profitable/JJ with/IN 
[ its/PRP$ research/NN work/NN ]
,/, 
[ Mr./NNP Panoz/NNP ]
was/VBD dissatisfied/JJ with/IN 
[ its/PRP$ potential/NN ]
for/IN 
[ revenue/NN growth/NN ]
and/CC 
[ its/PRP$ ability/NN ]
to/TO project/VB 
[ revenue/NN ]
from/IN 
[ year/NN ]
to/TO 
[ year/NN ]
./. 

``/`` 
[ Research/NN ]
and/CC 
[ development/NN companies.../:  ]
have/VBP 
[ no/DT solid/JJ source/NN ]
of/IN 
[ revenue/NN ]
''/'' because/IN 
[ they/PRP ]
have/VBP 
[ no/DT control/NN ]
over/IN bringing/VBG 
[ products/NNS ]
to/TO 
[ market/NN ]
,/, says/VBZ 
[ Mr./NNP Panoz/NNP ]
,/, 
[ who/WP ]
is/VBZ 
[ Elan/NNP 's/POS chairman/NN ]
,/, 
[ chief/JJ executive/JJ officer/NN ]
and/CC 
[ its/PRP$ largest/JJS individual/JJ stockholder/NN ]
./. 

======================================

So/RB for/IN 
[ the/DT past/JJ two/CD years/NNS ]

[ he/PRP ]
has/VBZ been/VBN working/VBG in/IN 
[ the/DT Irish/JJ midlands/NNS town/NN ]
of/IN 
[ Athlone/NNP ]
to/TO transform/VB 
[ the/DT company/NN ]
into/IN 
[ a/DT full-fledged/JJ international/JJ drug/NN manufacturer/NN ]
,/, especially/RB for/IN 
[ niche/NN markets/NNS ]
./. 

[ It/PRP ]
's/VBZ too/RB soon/RB to/TO tell/VB whether/IN 
[ the/DT move/NN ]
will/MD pay/VB off/RP ,/, and/CC 
[ a/DT decision/NN ]
to/TO develop/VB 
[ an/DT anti-AIDS/JJ drug/NN ]
has/VBZ brought/VBN 
[ an/DT unknown/JJ quantity/NN ]
to/TO 
[ the/DT mix/NN ]
./. 

======================================

[ The/DT biggest/JJS ingredient/NN ]
in/IN 
[ the/DT company/NN 's/POS favor/NN ]
is/VBZ 
[ a/DT twice-a-day/JJ formula/NN ]
of/IN 
[ Cardizem/NNP ]
,/, 
[ one/CD ]
of/IN 
[ the/DT U.S./NNP 's/POS best-selling/JJ cardiovascular/JJ drugs/NNS ]
./. 

[ Elan/NNP ]
developed/VBD 
[ a/DT more/RBR efficient/JJ version/NN ]
,/, 
[ Cardizem/NNP SR/NNP ]
,/, for/IN 
[ Marion/NNP Laboratories/NNP ]
and/CC struck/VBD 
[ a/DT deal/NN ]
with/IN 
[ Marion/NNP ]
to/TO manufacture/VB 
[ the/DT drug/NN ]
for/IN 
[ the/DT U.S./NNP market/NN ]
./. 

[ Elan/NNP ]
also/RB has/VBZ developed/VBN 
[ an/DT antismoking/JJ nicotine/NN patch/NN ]
./. 

======================================

But/CC 
[ Elan/NNP ]
has/VBZ departed/VBN from/IN 
[ its/PRP$ ]
normally/RB 
[ cautious/JJ strategy/NN ]
by/IN deciding/VBG to/TO gamble/VB on/IN developing/VBG 
[ an/DT anti-AIDS/JJ drug/NN ]
./. 

[ Mr./NNP Panoz/NNP ]
estimates/VBZ that/IN 
[ the/DT company/NN ]
is/VBZ spending/VBG more/JJR than/IN 
[ 10/CD %/NN ]
of/IN 
[ total/JJ revenue/NN ]
on/IN 
[ the/DT drug/NN ]
./. 

While/IN 
[ involvement/NN ]
in/IN 
[ the/DT anti-AIDS/JJ race/NN ]
gives/VBZ 
[ the/DT company/NN new/JJ potential/NN ]
,/, 
[ analysts/NNS ]
wonder/VBP whether/IN 
[ it/PRP ]
might/MD do/VB 
[ Elan/NNP more/JJR harm/NN ]
than/IN 
[ good/NN ]
./. 

[ Some/DT worry/NN ]
that/IN 
[ Elan/NNP ]
could/MD end/VB up/RP looking/VBG too/RB much/RB like/IN 
[ the/DT pharmacuetical/JJ industry/NN pariah/NN ]
,/, 
[ a/DT one-drug/JJ company/NN ]
./. 

======================================

Nevertheless/RB ,/, 
[ Terry/NNP Devitt/NNP ]
,/, 
[ equities/NNS analyst/NN ]
with/IN 
[ NCB/NNP Stockbrokers/NNP ]
,/, calls/VBZ 
[ the/DT plan/NN ]
to/TO become/VB 
[ a/DT manufacturer/NN ]

[ a/DT ]
``/`` 
[ heroic/JJ move/NN ]
./. 

''/'' 
[ Elan/NNP ]
,/, 
[ he/PRP ]
says/VBZ ,/, is/VBZ ``/`` 
[ the/DT most/RBS sophisticated/JJ ]
''/'' 
[ indigenous/JJ company/NN ]
in/IN 
[ Ireland/NNP 's/POS ]
burgeoning/VBG 
[ pharmaceutical/JJ industry/NN ]
./. 

``/`` 
[ There/EX ]
is/VBZ 
[ no/DT other/JJ company/NN ]

[ that/WDT ]
has/VBZ perfected/VBN 
[ the/DT same/JJ range/NN ]
of/IN 
[ delivery/NN systems/NNS ]
,/, ''/'' 
[ he/PRP ]
says/VBZ ./. 

But/CC ,/, 
[ he/PRP ]
adds/VBZ ,/, ``/`` 
[ the/DT bottom/JJ line/NN ]
is/VBZ 
[ the/DT kind/NN ]
of/IN 
[ challenge/NN ]

[ they/PRP ]
have/VBP taken/VBN on/RP ,/, and/CC 
[ it/PRP ]
's/VBZ very/RB ,/, very/RB different/JJ from/IN 
[ anything/NN ]

[ they/PRP ]
have/VBP taken/VBN on/RP in/IN 
[ the/DT past/NN ]
./. 

''/'' 
======================================

How/WRB 
[ difficult/JJ the/DT transition/NN ]
from/IN 
[ drug/NN researcher/NN ]
to/TO 
[ manufacturer/NN ]
can/MD be/VB was/VBD demonstrated/VBN in/IN 
[ the/DT first/JJ full/JJ fiscal/JJ year/NN ]
of/IN 
[ the/DT company/NN 's/POS new/JJ strategy/NN ]
,/, 
[ which/WDT ]
ended/VBD 
[ March/NNP 31/CD ]
,/, 
[ l988/CD ]
./. 

Because/IN of/IN 
[ research/NN costs/NNS ]
and/CC 
[ manufacturing/NN delays/NNS ]
,/, 
[ Elan/NNP ]
posted/VBD 
[ a/DT loss/NN ]
of/IN 
[ 2.3/CD million/CD Irish/JJ pounds/NNS ]
 (/( 
[ $/$ 3.1/CD million/CD ]
 )/) on/IN 
[ revenue/NN ]
of/IN 
[ 6.9/CD million/CD Irish/JJ pounds/NNS ]
./. 

But/CC 
[ figures/NNS ]
for/IN 
[ the/DT latest/JJS fiscal/JJ year/NN ]
show/VBP 
[ a/DT return/NN ]
to/TO 
[ profitability/NN ]
,/, with/IN 
[ earnings/NNS ]
of/IN 
[ 1.6/CD million/CD Irish/JJ pounds/NNS ]
on/IN 
[ revenue/NN ]
of/IN 
[ 16.2/CD million/CD Irish/JJ pounds/NNS ]
./. 

======================================

[ The/DT U.S./NNP Food/NNP ]
and/CC 
[ Drug/NNP Administration/NNP ]
granted/VBD 
[ permission/NN ]
for/IN 
[ Elan/NNP ]
to/TO begin/VB 
[ human/JJ trials/NNS ]
of/IN 
[ the/DT anti-AIDS/JJ drug/NN ]
,/, called/VBN 
[ EL-10/NNP ]
,/, 
[ last/JJ November/NNP ]
./. 

[ EL-10/NNP ]
,/, based/VBN on/IN 
[ a/DT hormone/NN ]
secreted/VBN by/IN 
[ the/DT adrenal/JJ gland/NN ]
,/, was/VBD developed/VBN in/IN 
[ 1987/CD ]
by/IN 
[ a/DT County/NNP Kildare/NNP microbiologist/NN ]
,/, 
[ Pat/NNP Prendergast/NNP ]
./. 

======================================

[ The/DT drug/NN 's/POS FDA-approved/JJ human/JJ tests/NNS ]
now/RB under/IN 
[ way/NN ]
in/IN 
[ San/NNP Francisco/NNP ]
mark/VBP 
[ the/DT second/JJ time/NN ]
acquired/JJ 
[ immune/JJ deficiency/NN syndrome/NN patients/NNS ]
in/IN 
[ the/DT U.S./NNP ]
have/VBP encountered/VBN 
[ the/DT drug/NN ]
./. 

In/IN early/JJ 
[ 1987/CD ]
,/, 
[ Mr./NNP Prendergast/NNP ]
took/VBD 
[ 10/CD San/NNP Francisco/NNP AIDS/NNP patients/NNS ]
to/TO 
[ Paris/NNP ]
and/CC carried/VBD out/RP 
[ six/CD months/NNS ]
of/IN 
[ tests/NNS ]
in/IN 
[ association/NN ]
with/IN 
[ doctors/NNS ]
at/IN 
[ the/DT Louis/NNP Pasteur/NNP Institute/NNP ]
./. 

[ All/DT ]
but/IN 
[ one/CD ]
of/IN 
[ that/DT group/NN ]
of/IN 
[ patients/NNS ]
have/VBP remained/VBN on/IN 
[ EL-10/NNP ]
./. 

[ Mr./NNP Prendergast/NNP ]
says/VBZ 
[ the/DT disease/NN 's/POS progress/NN ]
in/IN 
[ those/DT patients/NNS ]
appears/VBZ to/TO have/VB been/VBN arrested/VBN by/IN 
[ EL-10/NNP ]
./. 

======================================

But/CC 
[ Mr./NNP Panoz/NNP ]
is/VBZ careful/JJ not/RB to/TO forecast/VB 
[ great/JJ success/NN ]
for/IN 
[ the/DT drug/NN ]
or/CC to/TO project/VB 
[ the/DT idea/NN ]
that/IN 
[ the/DT company/NN 's/POS future/NN ]
is/VBZ totally/RB dependent/JJ upon/IN 
[ it/PRP ]
./. 

``/`` 
[ The/DT pure/JJ fact/NN ]
is/VBZ 
[ there/EX ]
is/VBZ no/DT ,/, 
[ there/EX ]
is/VBZ 
[ zero/CD ]
,/, 
[ clinical/JJ evidence/NN ]

[ that/WDT ]
shows/VBZ that/WDT 
[ EL-10/NNP works/VBZ ]
./. 

At/IN 
[ this/DT juncture/NN ]
,/, 
[ there/EX ]
are/VBP 
[ indications/NNS ]
,/, ''/'' 
[ he/PRP ]
says/VBZ ./. 

======================================

[ It/PRP ]
has/VBZ taken/VBN 
[ Mr./NNP Panoz/NNP more/RBR ]
than/IN 
[ a/DT decade/NN ]
to/TO establish/VB 
[ Elan/NNP ]
as/IN 
[ a/DT company/NN ]
with/IN 
[ a/DT niche/NN technology/NN ]
to/TO sell/VB ./. 

In/IN 
[ 1987/CD ]
,/, with/IN about/RB 
[ 50/CD license/NN arrangements/NNS ]
and/CC 
[ 30/CD clients/NNS ]
,/, 
[ the/DT company/NN ]
decided/VBD to/TO set/VB 
[ an/DT independent/JJ course/NN ]
,/, using/VBG 
[ contract/NN research/NN ]
as/IN ``/`` 
[ the/DT engine/NN ]
./. 

''/'' 
======================================

[ Cardizem/NNP SR/NNP ]
was/VBD ready/JJ for/IN 
[ approval/NN ]
as/IN 
[ a/DT treatment/NN ]
for/IN 
[ hypertension/NN ]
as/RB well/RB as/IN 
[ angina/NN ]
,/, and/CC 
[ Elan/NNP ]
had/VBD worked/VBN out/RP 
[ the/DT arrangement/NN ]
to/TO manufacture/VB 
[ it/PRP ]
for/IN 
[ Marion/NNP ]
,/, 
[ which/WDT ]
is/VBZ in/IN 
[ the/DT process/NN ]
of/IN merging/VBG with/IN 
[ Dow/NNP Chemical/NNP Co./NNP 's/POS Merrell/NNP Dow/NNP Pharmaceuticals/NNP subsidiary/NN ]
./. 

[ Elan/NNP ]
also/RB had/VBD developed/VBN 
[ a/DT new/JJ liquid-drug/JJ delivery/NN system/NN ]
for/IN 
[ the/DT pediatric/JJ ]
and/CC 
[ geriatric/JJ markets/NNS ]
./. 

[ Work/NN ]
on/IN 
[ its/PRP$ nicotine/NN patch/NN ]
was/VBD complete/JJ ,/, and/CC 
[ it/PRP ]
had/VBD 
[ EL-10/NNP ]
./. 

But/CC 
[ the/DT strategy/NN ]
meant/VBD 
[ a/DT 176/CD %/NN increase/NN ]
in/IN spending/NN on/IN 
[ research/NN ]
and/CC 
[ the/DT fiscal/JJ 1988/CD losses/NNS ]
./. 

======================================

[ NCB/NNP 's/POS Mr./NNP Devitt/NNP ]
thinks/VBZ 
[ the/DT company/NN ]
will/MD need/VB 
[ another/DT year/NN ]
before/IN 
[ it/PRP ]
can/MD prove/VB 
[ it/PRP ]
can/MD handle/VB 
[ the/DT challenges/NNS ]
of/IN marketing/VBG|NN and/CC 
[ large-scale/JJ production/NN ]
./. 

[ Neil/NNP Buckley/NNP ]
,/, 
[ Director-General/NNP ]
of/IN 
[ the/DT Irish/NNP Federation/NNP ]
of/IN 
[ Chemical/NNP Industries/NNP ]
,/, agrees/VBZ that/IN 
[ it/PRP ]
may/MD be/VB ``/`` too/RB early/RB to/TO say/VB how/WRB well/RB 
[ they/PRP ]
have/VBP done/VBN ./. 

''/'' But/CC ,/, 
[ he/PRP ]
says/VBZ ,/, ``/`` 
[ they/PRP ]
are/VBP still/RB in/IN 
[ there/EX ]
,/, and/CC 
[ they/PRP ]
have/VBP 
[ every/DT prospect/NN ]
of/IN doing/VBG well/RB ./. 

But/CC 
[ it/PRP ]
is/VBZ 
[ a/DT niche/NN market/NN ]

[ they/PRP ]
are/VBP in/IN ,/, in/IN 
[ my/PRP$ view/NN ]
./. 

''/'' 
======================================

[ Mr./NNP Panoz/NNP ]
,/, however/RB ,/, is/VBZ happy/JJ with/IN 
[ a/DT niche-market/NN approach/NN ]
./. 

[ A/DT company/NN ]
,/, 
[ he/PRP ]
says/VBZ ,/, can/MD grow/VB from/IN 
[ niche/NN ]
to/TO 
[ niche/NN ]
./. 

[ A/DT lot/NN ]
of/IN 
[ niches/NNS ]
can/MD equal/VB 
[ a/DT pretty/RB big/JJ market/NN ]
,/, 
[ he/PRP ]
adds/VBZ ./. 
